Hand-held Optical Coherence Tomography Feasibility Older Hip Fracture
Optical Coherence Tomography Feasibility in Older People Following Hip Fracture Surgery
1 other identifier
interventional
30
1 country
1
Brief Summary
Assessment of the feasibility of achieving retinal imaging in older people with recent hips fracture surgery using hand held optical coherence tomography device
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2019
CompletedFirst Posted
Study publicly available on registry
August 1, 2019
CompletedStudy Start
First participant enrolled
September 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedMay 11, 2022
May 1, 2022
1.1 years
July 29, 2019
May 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Ability to achieve good quality retinal images
Retinal images with signal strength \> 6 and in which retinal layers can be measured
30 minutes
Ability to achieve imaging without causing pain
Patient reported pain during acquisition of images over their baseline. Scale of 0 - 10 where 0 is no increase in pain and 10 is severe increase in pain
Immediate
Study Arms (1)
All participants
EXPERIMENTALAll participants will have measurements taken. There are no comparators or controls in this feasibility study
Interventions
Non-invasive method of acquiring cross sectional imaging of tissues using the coherent property of light
Eligibility Criteria
You may qualify if:
- Recent hip fracture surgery
- Age \> 64 years
- No cognitive impairment
- Able to understand instructions given in English
- Consent
You may not qualify if:
- Presence of degenerative eye disease e.g. age-related macula degeneration, glaucoma, diabetic retinopathy, hypertensive retinopathy
- Dementia, mild cognitive impairment, Parkinson,s disease, multiple sclerosis, current delirium
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen's Medical Centre
Nottingham, Nottinghamshire, NG7 2UH, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Iain Moppett, PhD
University of Nottingham, Nottingham, UK
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2019
First Posted
August 1, 2019
Study Start
September 3, 2019
Primary Completion
October 1, 2020
Study Completion
October 1, 2020
Last Updated
May 11, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Start date 6 months after publication. End date 12 months after publication
- Access Criteria
- Researchers with a valid reason as reviewed by the lead investigator
De-identified individual participant data on our primary outcome will be made available